Isotretinoin and intestinal inflammation: What gastroenterologists need to know

Gut

Volumn 58, Issue 6, 2009, Pages 737-741

  Shale, Matthew ^a   Kaplan, Gilaad G ^b   Panaccione, Remo ^b   Ghosh, Subrata ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ISOTRETINOIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

COLITIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; ENTERITIS; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL RESEARCH; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; SMALL BOWEL INFLAMMATION; SMALL INTESTINE DISEASE;

ACNE VULGARIS; ADOLESCENT; ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; ISOTRETINOIN; MALE; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 66649099877     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.170530     Document Type: Review

References (47)

1. Card T, Logan RF, Rodrigues LC, et al. Antibiotic use and the development of Crohn's disease. Gut 2004;53:246-250 (Pubitemid 38125513)
2. Evans JM, McMahon AD, Murray FE, et al. Nonsteroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997;40:619-622 (Pubitemid 27278329)
3. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37:668-673
4. Brodin MB. Inflammatory bowel disease and isotretinoin. J Am Acad Dermatol 1986;14:843.
5. Martin P, Manley PN, Depew WT, et al. Isotretinoin-associated proctosigmoiditis. Gastroenterology 1987;93:606-609 (Pubitemid 17136888)
6. Reniers DE, Howard JM. Isotretinoin-induced inflammatory bowel disease in an adolescent. Ann Pharmacother 2001;35:1214-1216 (Pubitemid 32962568)
7. McGinn T, Bewira C. Isoretinoin (Accutane) associated pancolitis. Am J Gastroenterol 1997;92:1682.
8. Passier JL, Srivastava N, van Puijenbroek EP. Isotretinoin-induced inflammatory bowel disease. Neth J Med 2006;64:52-54 (Pubitemid 43285588)
9. Bankar RN, Dafe CO, Köhnke A, et al. Ulcerative colitis probably associated with isotretinoin. Indian J Gastroenterol 2006;25:171-172 (Pubitemid 44326070)
10. Rolanda C, Macedo G. Isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2007;102:1330.
11. Spada C, Riccioni ME, Marchese M, et al. Isotretinoin-associated pan-enteritis. J Clin Gastroenterol 2008;42:923-925
12. Reddy D, Siegel CA, Sands BE, et al. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2006;101:1569-1573 (Pubitemid 43980631)
13. Guslandi M. Isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2007;102:1546-1547
14. US Food and Drug Administration. Center for Drug Evaluation and Research website. Available at: http://www.fda.gov/cder/aers/extract.htm (accessed 6 October 2008).
15. Stern RS, Fitzgerald E, Ellis CN, et al. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study. J Am Acad Dermatol 1995;33:44-52.
16. Park SH, Gray WC, Hernandez I, et al. Phase I trial of all-trans-retinoic acid in patients with treated head and neck squamous carcinoma. Clin Cancer Res 2000;6:847-854 (Pubitemid 30159339)
17. Godfrey KM, James MP. Treatment of severe acne with isotretinoin in patients with inflammatory bowel disease. Br J Dermatol 1990;123:653-655 (Pubitemid 20377657)
18. Schleicher SM. Oral isotretinoin and inflammatory bowel disease. J Am Acad Dermatol 1985;13:834-835 (Pubitemid 16245163)
19. Bruno NP, Beacham BE, Burnett JW. Adverse effects of isotretinoin therapy. Cutis 1984;33:484-486 (Pubitemid 14101869)
20. McHenry PM, Hudson M, Smart LM, et al. Pyoderma faciale in a patient with Crohn's disease. Clin Exp Dermatol 1992;17:460-462 (Pubitemid 23026822)
21. Rosen T, Unkefer RP. Treatment of pyoderma faciale with isotretinoin in a patient with ulcerative colitis. Cutis 1999;64:107-109
22. Tsianos EV, Dalekos GN, Tzermias C, et al. Hidradenitis suppurativa in Crohn's disease. A further support to this association. J Clin Gastroenterol 1995;20:151-153
23. Scott HD, Rosenbaum SE, Waters WJ, et al. Rhode Island physicians' recognition and reporting of adverse drug reactions. Rhode Island Med J 1987;70:311-316
24. Törmä H. Interaction of isotretinoin with endogenous retinoids. J Am Acad Dermatol 2001;45:S143-9. (Pubitemid 33032593)
25. Rojanapo W, Lamb AJ, Olson JA. The prevalence, metabolism and migration of goblet cells in rat intestine following the induction of rapid, synchronous vitamin A deficiency. J Nutr 1980;110:178-188 (Pubitemid 10146000)
26. Kozakova H, Hanson LA, Stepankova R, et al. Vitamin A deficiency leads to severe functional disturbance of the intestinal epithelium enzymes associated with diarrhoea and increased bacterial translocation in gnotobiotic rats. Microb Infect 2003;5:405-411 (Pubitemid 36549182)
27. Stephensen CB. Vitamin A, infection and immune function. Ann Rev Nutrition 2001;21:167-192.
28. Jiang YJ, Xu TR, Lu B, et al. Cyclooxygenase expression is elevated in retinoic acid-differentiated U937 cells. Biochim Biophys Acta 2003;1633:51-60. (Pubitemid 36773946)
29. Gross V, Villiger PM, Zhang B, et al. Retinoic acid inhibits interleukin-1-induced cytokine synthesis in human monocytes. J Leuk Biol 1997;54:125-132
30. Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J, et al. Suppression of apoptosis by all-trans-retinoic acid. J Biol Chem 1999;274:20251-20258
31. Pigatto PD, Fioroni A, Riva F, et al. Effects of isotretinoin on the neutrophil chemotaxis in cystic acne. Dermatologica 1983;167:16-18
32. Bohne M, Struy H, Gerber A, et al. Effects of retinoids on the generation of neutrophil-derived reactive oxygen species studied by EPR spin trapping techniques. Inflamm Res 1997;46:423-424 (Pubitemid 27478603)
33. Marks DJ, Harbord MW, MacAllister R, et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006;367:668-678 (Pubitemid 43289157)
34. van Heel DA, Ghosh S, Butler M, et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 2005;365:1794-1796 (Pubitemid 40744660)
35. Mora JR, Iwata M, Eksteen B, et al. Generation of gut-homing IgA secreting B cells by intestinal dendritic cells. Science 2006;314:1157-1160 (Pubitemid 44789048)
36. Iwata M, Eshima Y, Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 2003;15:1017-1025 (Pubitemid 36987299)
37. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317:256-260 (Pubitemid 47076203)
38. Kang SG, Lim HW, Andrisani OM. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol 2007;179:3724-3733
39. Sun CM, Hall JA, Blank RB, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007;204:1775-1785 (Pubitemid 47236316)
40. Coombes JL, Siddiqui KR, Rancibia-Carcamo CV, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007;204:1757-1764 (Pubitemid 47236314)
41. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849-1861 (Pubitemid 47240944)
42. Kobayashi T, Okamoto S, Hisamatsu T, et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008;57:1682-1689
43. Benson MJ, Pino-Lagos K, Rosemblatt M, et al. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007;204:1765-1774 (Pubitemid 47236315)
44. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genetics 2008;40:955-962
45. Jounai N, Takeshita F, Kobiyama K, et al. The Atg5-Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA 2007;104:14050-14055 (Pubitemid 350003333)
46. Online. http://articles.latimes.com/2007/may/30/business/fi-accutane30 (acessed 6 October 2008).
47. Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000;47:506-513